Following the announcement that Victoria Espinel, the first US Intellectual Enforcement Property Coordinator, will be stepping down from her post, reports say White House regulatory czar Howard Shelanski will step in as acting IPEC. Espinel served for four years in the position.
Shelanski was appointed by the Obama administration earlier this year to become regulatory czar, a high-profile position in the White House responsible for reviewing government department regulatory proposals. He previously served as the Director of the Bureau of Economics at the FTC since July 2012; FTC Chairwoman Edith Ramirez announced his departure from the agency last July.
The position of IPEC was formed through the Prioritizing Resources and Organization for Intellectual Property Act of 2008 and aims to assist government agencies and officials – including the White House – on intellectual property issues.
The position also enforces foreign trade agreements. Intellectual property is a topic often hit with antitrust issues. Most recently, the issue surrounds a recent spat between smart phone rivals Apple and Samsung, who have sued each other and earned import bans for phones that infringe on each other’s patents.
Full Content: PatentDocs.org
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas